Racura Oncology Ltd ABN 61 149 318 749 Registered office: L36, 1 Macquarie Place, Sydney NSW 2000 www.Racuraoncology.com Page 1 of 19 Racura Oncology Ltd Corporate Governance Statement The Board of...
Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Racura Oncology
- Appendix 4G
- Appendix 4E & Annual Report
- First HARNESS-1 Patient Safely Treated with RC220
- Racure Oncology Techknow Invest Presentation
- June 2026 Quarterly Activities Report and Appendix 4C
Later from Racura Oncology
- CPACS Trial Opens for RC220 Patient Enrolment in Korea
- Notification regarding unquoted securities - RAC
- Racura Oncology Adelaide Investor Briefing
- RC220 MYC-silencing data to be presented FCS 26 conference
- Appendix 3Y - Dr Daniel Tillett
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology